Key result
Four-variable clinical score accurately identifies definite CIED infection with ~0.94 AUC.
Why the study?
No prediction score exists for cardiovascular implantable electronic device infection in patients with non-Staphylococcus aureus bacteremia without pocket infection.
Observational (n=282)
No
Effect estimate: AUC 0.940
A novel four-variable risk score can accurately predict the probability of definite CIED infection in patients with non-S. aureus bacteremia, potentially guiding early device-focused evaluation.
May aid risk stratification for CIED infection in non-S. aureus bacteremia; leaves open prospective validation before clinical adoption.
BACKGROUND: Patients with cardiovascular implantable electronic devices (CIEDs) who develop bacteremia require risk stratification for device infection. Although prediction scores exist for Staphylococcus aureus bacteremia, no comparable CIED-specific tool exists for non-S. aureus bacteremia. Our study aimed to estimate the probability of definite CIED infection in adults with non-S. aureus bacteremia without pocket infection. METHODS: We performed a prediction-model analysis of adults with CIEDs and non-S. aureus bacteremia, comprising gram-negative bacteremia (GNB) and gram-positive cocci other than S. aureus (GPC) bacteremia, at Mayo Clinic Rochester during 2012-2019. Patients with pocket infection were excluded. Definite CIED infection was classified using 2019 European Heart Rhythm Association criteria. Penalized logistic regression was used to construct two prediction models for definite infection: a full model with nine prespecified predictors, and a reduced model from which a point-based risk score could be obtained. RESULTS: A total of 282 patients with CIEDs developed non-S. aureus bacteremia. Median age was 75 years; 69% were men. GPC bacteremia occurred in 156 patients (55%) and GNB in 126 (45%). Sixty patients (21%) had definite CIED infection. Both the full and reduced models demonstrated excellent predictive discrimination (apparent area under receiver operating characteristic curve 0.946 and 0.940). The reduced model retained four predictors: GPC bacteremia, persistent bacteremia, longer time to positivity, and unknown bacteremia source. CONCLUSION: A four-variable risk score incorporating organism category, persistent bacteremia, time to positivity, and unknown bacteremia source may guide early device-focused evaluation, but external validation is required before clinical adoption.
No takes yet. Share an insight, caveat, or question.
Chesdachai et al. (2026) conducted an observational in Non-Staphylococcus aureus bacteremia in patients with cardiovascular implantable electronic devices (n=282). Four-variable risk score was evaluated on Definite CIED infection (AUC 0.940). A four-variable risk score incorporating organism category, persistent bacteremia, time to positivity, and unknown bacteremia source demonstrated excellent predictive discrimination (AUC 0.940) for definite CIED infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: